2026-04-17T12:57:30Zhttps://riubu.ubu.es/oai/request

oai:riubu.ubu.es:10259/100372025-01-25T01:05:28Zcom_10259_6688com_10259_5086com_10259_2604col_10259_6689

00925njm 22002777a 4500 dc Davalos, Veronica author García-Prieto, Carlos A. author Ferrer, Gerardo author Aguilera-Albesa, Sergio author Valencia Ramos, Juan author Rodríguez-Palmero, Agustí author Ruiz, Montserrat author Planas-Serra, Laura author Jordan, Iolanda author Alegría, Iosune author Flores-Pérez, Patricia author Cantarín, Verónica author Fumadó, Victoria author Viadero, Maria Teresa author Rodrigo, Carlos author Méndez-Hernández, Maria author López-Granados, Eduardo author Colobran, Roger author Rivière, Jacques G. author Soler-Palacín, Pere author Pujol, Aurora author Esteller, Manel author 2022-08 Most children and adolescents infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain asymptomatic or develop a mild coronavirus disease 2019 (COVID-19) that usually does not require medical intervention. However, a small proportion of pediatric patients develop a severe clinical condition, multisystem inflammatory syndrome in children (MIS-C). The involvement of epigenetics in the control of the immune response and viral activity prompted us to carry out an epigenomic study to uncover target loci regulated by DNA methylation that could be altered upon the appearance of MIS-C. 2589-5370 http://hdl.handle.net/10259/10037 10.1016/J.ECLINM.2022.101515 Multisystem inflammatory syndrome in children COVID-19 Kawasaki disease Epigenetics DNA methylation Epigenetic profiling linked to multisystem inflammatory syndrome in children (MIS-C): A multicenter, retrospective study